Skip to content

Pilot study on intelligent comprehensive continuous intervention of cognitive impairment based on family and community

Pilot study on intelligent comprehensive continuous intervention of cognitive impairment based on family and community

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200061420
Enrollment
Unknown
Registered
2022-06-24
Start date
2020-06-01
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

mild cognitive impairment (MCI)

Interventions

intervention group (the healthy elderly):multicomponent intervention
control group (the healthy elderly):health education
intervention group (the elderly with MCI):multicomponent intervention
control group (the elderly with MCI):health education

Sponsors

Fudan University School of Public Health
Lead Sponsor

Eligibility

Sex/Gender
All
Age
55 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. No gender limit, aged 55-75 years; 2. Education level: primary school or above; 3. Chief complaint of memory loss within the past year; 4. Clinically diagnosed as MCI or cognitively normal; 5. Not taking medication for cognitive impairment; 6. Free movement, good compliance, able to adhere to the completion of intervention courses.

Exclusion criteria

Exclusion criteria: 1. Cognitive decline due to other diseases (including but not limited to: cerebrovascular diseases, central nervous system infections, Parkinson's disease, metabolic encephalopathy, folic acid and vitamin B12 deficiencies, and hypothyroidism); 2. Have suffered from neurological diseases (stroke, Parkinson's disease, epilepsy, etc.); 3. Mental Disorders included in The Diagnostic and Statistical Manual of Mental Disorders (DSM-5) of the American Psychiatric Association; 4. Serious diseases of the heart, lung, liver, kidney and hematopoietic system; 5. Participated in other similar cognitive intervention trials within 30 days before the screening of this study; 6. Other reasons for failing to complete the study.

Design outcomes

Primary

MeasureTime frame
global cognitive function;executive function;

Secondary

MeasureTime frame
memory function;attention;magnetic resonance imaging;

Countries

China

Contacts

Public ContactWang Ying

Fudan University School of Public Health

wangying1013@fudan.edu.cn+86 13564660698

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026